Literature DB >> 25739891

Expression of Fgf23 in activated dendritic cells and macrophages in response to immunological stimuli in mice.

Yuki Masuda1, Hiroya Ohta, Yumiko Morita, Yoshiaki Nakayama, Ayumi Miyake, Nobuyuki Itoh, Morichika Konishi.   

Abstract

Fibroblast growth factors (Fgfs) are polypeptide growth factors with diverse biological activities. While several studies have revealed that Fgf23 plays important roles in the regulation of phosphate and vitamin D metabolism, the additional physiological roles of Fgf23 remain unclear. Although it is believed that osteoblasts/osteocytes are the main sources of Fgf23, we previously found that Fgf23 mRNA is also expressed in the mouse thymus, suggesting that it might be involved in the immune system. In this study we examined the potential roles of Fgf23 in immunological responses. Mouse serum Fgf23 levels were significantly increased following inoculation with Escherichia coli or Staphylococcus aureus or intraperitoneal injection of lipopolysaccharide. We also identified activated dendritic cells and macrophages that potentially contributed to increased serum Fgf23 levels. Nuclear factor-kappa B (NF-κB) signaling was essential for the induction of Fgf23 expression in dendritic cells in response to immunological stimuli. Moreover, we examined the effects of recombinant Fgf23 protein on immune cells in vitro. Fgfr1c, a potential receptor for Fgf23, was abundantly expressed in macrophages, suggesting that Fgf23 might be involved in signal transduction in these cells. Our data suggest that Fgf23 potentially increases the number in macrophages and induces expression of tumor necrosis factor-α (TNF-α), a proinflammatory cytokine. Collectively, these data suggest that Fgf23 might be intimately involved in inflammatory processes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25739891     DOI: 10.1248/bpb.b14-00276

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  32 in total

Review 1.  Biology of Fibroblast Growth Factor 23: From Physiology to Pathology.

Authors:  Marie Courbebaisse; Beate Lanske
Journal:  Cold Spring Harb Perspect Med       Date:  2018-05-01       Impact factor: 6.915

Review 2.  Ironing out the cross talk between FGF23 and inflammation.

Authors:  Valentin David; Connor Francis; Jodie L Babitt
Journal:  Am J Physiol Renal Physiol       Date:  2016-08-31

3.  p38MAPK controls fibroblast growth factor 23 (FGF23) synthesis in UMR106-osteoblast-like cells and in IDG-SW3 osteocytes.

Authors:  F Ewendt; M Föller
Journal:  J Endocrinol Invest       Date:  2019-06-14       Impact factor: 4.256

Review 4.  Extrarenal effects of FGF23.

Authors:  Dieter Haffner; Maren Leifheit-Nestler
Journal:  Pediatr Nephrol       Date:  2016-10-04       Impact factor: 3.714

5.  Tissue sodium content in patients with systemic lupus erythematosus: association with disease activity and markers of inflammation.

Authors:  D A Carranza-León; A Oeser; A Marton; P Wang; J C Gore; J Titze; C M Stein; C P Chung; M J Ormseth
Journal:  Lupus       Date:  2020-02-18       Impact factor: 2.911

6.  Spleen contributes significantly to increased circulating levels of fibroblast growth factor 23 in response to lipopolysaccharide-induced inflammation.

Authors:  Shweta Bansal; William E Friedrichs; Chakradhar Velagapudi; Denis Feliers; Khaled Khazim; Diane Horn; John E Cornell; Sherry L Werner; Paolo Fanti
Journal:  Nephrol Dial Transplant       Date:  2017-06-01       Impact factor: 5.992

7.  Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease.

Authors:  Saurav Singh; Alexander Grabner; Christopher Yanucil; Karla Schramm; Brian Czaya; Stefanie Krick; Mark J Czaja; Rene Bartz; Reimar Abraham; Giovana S Di Marco; Marcus Brand; Myles Wolf; Christian Faul
Journal:  Kidney Int       Date:  2016-07-22       Impact factor: 10.612

8.  Counter-regulatory paracrine actions of FGF-23 and 1,25(OH)2 D in macrophages.

Authors:  Xiaobin Han; Linqiang Li; Jiancheng Yang; Gwendalyn King; Zhousheng Xiao; Leigh Darryl Quarles
Journal:  FEBS Lett       Date:  2016-01-09       Impact factor: 4.124

9.  Calcineurin inhibitors regulate fibroblast growth factor 23 (FGF23) synthesis.

Authors:  Ludmilla Bär; Claudia Großmann; Michael Gekle; Michael Föller
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-07-31       Impact factor: 3.000

10.  Biomarkers of Mineral and Bone Metabolism and 20-Year Risk of Hospitalization With Infection: The Atherosclerosis Risk in Communities Study.

Authors:  Junichi Ishigami; Bernard G Jaar; Casey M Rebholz; Morgan E Grams; Erin D Michos; Myles Wolf; Csaba P Kovesdy; Shinichi Uchida; Josef Coresh; Pamela L Lutsey; Kunihiro Matsushita
Journal:  J Clin Endocrinol Metab       Date:  2017-12-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.